Orchestra BioMed (OBIO)
Develops partnership-enabled device therapies for hypertension and artery disease.
$5.94
vs last close−0.28 (−4.50%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 46.66% | 28.04M shares | |
|---|---|---|---|
| 81 holders · as of Jun 30, 2026 | |||
| Insiders | 6.13% | 3.69M shares | |
| 10 holders · as of Sep 11, 2026 | |||
| Strategic holders | 21.51% | 12.93M shares | |
| 2 holders · as of Feb 27, 2026 | |||
| Other | 25.70% | 15.45M shares | |
| remainder | |||
60.11M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
81 holders · 28.04M shares · 26 new positions · 48 increased · 15 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| RTW Investments, LP | 9.56M | 15.90% | +1.25M | Aug 14, 2026 |
| Perceptive Advisors LLC | 5.04M | 8.38% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 2.51M | 4.18% | +1.87M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 2.02M | 3.37% | −181.4K | Aug 13, 2026 |
| Geode Capital Management, LLC | 1.01M | 1.68% | +522.4K | Aug 12, 2026 |
| Alyeska Investment Group, L.P. | 1.00M | 1.66% | 0 | Aug 14, 2026 |
| Propel Bio Management, LLC | 896.7K | 1.49% | 0 | Aug 13, 2026 |
| UBS Asset Management Americas Inc | 642.2K | 1.07% | +642.2Knew | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Roderick Wongincl. RTW Innovation Master Fund, Ltd., RTW Investments, LP +1 more | 19.20% | 11.94M | 13D | Apr 29, 2026 |
| Medtronic plc | 17.80% | 10.08M | 13G | Feb 27, 2026 |
| Perceptive Advisors LLC | 9.99% | 5.68M | 13G | Nov 14, 2025 |
| BlackRock, Inc. | 5.10% | 1.94M | Nov 8, 2024 | |
| Tasso Partners, LLC | 5.00% | 2.85M | 13G | Nov 19, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 3, 2026 | David P. Hochmandirector, officer: See Remarks | Purchase | 10,000 | $4.79 | 1,070,746 |
| Sep 1, 2026 | Darren Shermandirector, officer: See Remarks | Sale | 15,000 | $4.94 | 1,134,402 |
| Aug 26, 2026 | Darren Shermandirector, officer: See Remarks | Purchase | 2,000 | $5.33 | 2,000 |
| Aug 3, 2026 | Darren Shermandirector, officer: See Remarks | Sale | 15,000 | $4.09 | 1,154,327 |
| Jul 1, 2026 | Darren Shermandirector, officer: See Remarks | Sale | 15,000 | $4.27 | 1,169,327 |
| Jun 1, 2026 | Darren Shermandirector, officer: See Remarks | Sale | 15,000 | $3.87 | 1,184,327 |
| Jun 1, 2026 | David P. Hochmandirector, officer: See Remarks | Purchase | 5,000 | $3.83 | 1,064,029 |
| May 18, 2026 | Jason Aryehdirector | Purchase | 665 | $3.75 | 118,118 |
| May 15, 2026 | David P. Hochmandirector, officer: See Remarks | Purchase | 5,000 | $3.77 | 1,059,029 |
| May 15, 2026 | Jason Aryehdirector | Purchase | 8,971 | $3.90 | 117,453 |
House and Senate disclosures
Not reported.